Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score‐matched nested case–control study

Abstract

Evidence on acute respiratory failure (ARF) from antipsychotics is scant, and only 1 population-based study examined this drug safety issue in chronic obstructive pulmonary disease patients. Antipsychotics have been frequently prescribed off-label in adults, but whether antipsychotic use carries an increased ARF risk among adult patients is uncertain. Methods: We adopted a nested case-control study analysing 716 493 adults aged ≥20 years, identified from the Taiwan nationwide healthcare claims records between January 2000 and December 2013. Among the study cohort, 7084 adults with ARF and 12,785 disease risk scored-matched randomly selected controls were analysed. Multivariable logistic regression models were employed to estimate odds ratios of ARF with antipsychotic usages. Results: Current, recent, and recent past use of antipsychotics was associated with a 2.33-fold (95% confidence interval [CI] = 2.06-2.64), 1.79-fold (95% CI = 1.43-2.25) and 1.41-fold (95% CI = 1.20-1.66) increased risk of ARF, respectively, compared with nonuse, while antipsychotics discontinued >90 days carried no risk. A dosedependent association was observed with current therapy of antipsychotics (test for trend, P < .001), in which antipsychotic use at >1 defined daily dose yielded the highest risk of 6.53-fold (95% CI = 3.33-12.79). The findings were robust to using carbamazepine as an active comparator. Conclusion: Antipsychotic use was associated with an increased risk of ARF in adult patients. The risk was dose-dependent and markedly higher with current use of antipsychotic agents at doses of 1 defined daily dose and above, <10% of this cohort. Physicians should be vigilant about any respiratory symptoms in patients currently receiving antipsychotics at such dose.

Somatic Implications in Hospitalized Patients with Chronic Schizophrenia

“…(18) Recently, respiratory side effects of antipsychotics such as acute respiratory failure have also been described in literature, side effects reported as well by our patients. (19) We noticed in our study the frequent use of benzodiazepines as an adjuvant treatment, especially alprazolam and clonazepam. Although both compounds are benzodiazepines derivatives, their indications are different.…”

Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches

“…In general, men smoke more than women and are more exposed to toxic industrial fumes, although women are more likely to develop allergic reactions to air particles [ 42 ]. Sedative antipsychotics may undermine deep breathing in both sexes [ 43 ].…”

Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study

“…Based on previous studies and the elimination half-lives of antipsychotics (Additional file 1 : Table S1) [ 17 , 18 ], we defined the case and control periods as 1–14 days and 75–88 days, respectively, before severe asthma exacerbation (Fig. 1 b).…”